Illumina’s accelerator has an impressive 93 percent follow-on funding rate — here’re its latest picks
Because its inaugural friend in 2014, around 93 percent of its graduates have actually gone on to raise extra capital.”As we browse the current global pandemic, there is an even stronger urgency to produce advancement genomics startups that will transform human health and beyond,” said Amanda Cashin, Co-founder and Global Head of Illumina Accelerator, in a statement.
Considering that its inaugural cohort in 2014, around 93 percent of its graduates have gone on to raise additional capital.”As we navigate the existing worldwide pandemic, there is an even more powerful seriousness to produce development genomics start-ups that will transform human health and beyond,” said Amanda Cashin, Co-founder and Global Head of Illumina Accelerator, in a statement.